NextGen Omics & Spatial Biology US 2025

27 - 28 March 2025 | Boston, MA

Leveraging multi-omic data to unlock transformative insights into cellular biology, disease and drug discovery

Omics Hero Banner Circle Image
Overview NGS, Clinical Omics & Diagnostics Single Cell Spatial Multi-Omics

Explore NextGen Omics & Spatial Biology US 2025: Advancing Therapeutic Innovation Through Multi-Omic Analysis – Celebrating its 11th Year. 

Join us at NextGen Omics & Spatial Biology US 2025, a premier event celebrating its 11th year of advancing therapeutic innovation through multi-omic analysis. This gathering brings together over 1,000 senior experts in multi-omics and spatial analysis from leading pharmaceutical, biotech, and life sciences companies, creating a vibrant platform for collaboration and innovation. 

Over the course of two action-packed days in March, participants will have the chance to accelerate the adoption of cutting-edge multi-omic and spatial techniques in drug discovery and clinical research. The event will feature a diverse array of presentations, panel discussions, and interactive workshops, offering deep dives into the latest advancements and practical applications. 

Attendees will engage in meaningful discussions about the industry’s most pressing challenges, ranging from data analysis and reproducibility to sample management and clinical design. These conversations will provide invaluable insights and foster collaborations that can drive the field forward. 

Whether you are looking to enhance your current projects, explore new directions, or simply stay abreast of the latest trends and technologies, NextGen Omics and Spatial Biology US 2025 is the place to be. 

Don’t miss out on this opportunity to be at the forefront of multi-omic and spatial biology innovation, contributing to the future of drug discovery and clinical research. Join us and be part of the conversation that shapes the next decade of therapeutic development. 

NGS, Clinical Omics & Diagnostics

Expand the applications of next-generation sequencing in your clinical & diagnostic workflows through Next Generation Sequencing & Clinical Diagnostics, highlighting the most need-to-know innovations in diagnostics, clinical genomics & bioinformatic technologies. Industry leading speakers will showcase effective strategies for integrating NGS techniques within drug development, with further discussion on standardizing bioinformatics, optimizing NGS-based assays and utilizing multi-omic data.

  • Over 600 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 50 presentations focussed on the critical issues in NGS implementation and data integration
  • Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets
  • Discuss digital PCR & liquid biopsies. Hear from key opinion leaders’ in-depth presentations on PCR machines for NGS library preparation, developing nextgen MRD assays and advances in analysing cell-free DNA & CTCs  

Agenda at a Glance


  • Day One | Track 1: Advanced Sequencing Technologies
  • Day One | Track 2: Multi Omics Data Harmonization, Integration & Analysis
  • Day One | Track 3: Digital PCR & Liquid Biopsies
  • Day Two | Track 1: Novel Diagnostics For Infectious & Non-Infectious Disease
  • Day Two | Track 2: Applying Multi-Omics in the Clinic

Single Cell Analysis

Recent advances in single cell analytical tools have enabled increasingly deep cellular analyses at the genomic, transcriptomic and proteomic level. Join Single Cell Analysis to learn how to integrate the most exciting new techniques within drug development, from identifying novel therapeutic targets through to understanding patient responses to specific therapies. In-depth case studies also showcase emerging spatial approaches, with discussion on how to optimize their use within R&D.

  • Over 450 end users representing internationally renowned research & academic institutions, healthcare organisations and leading biopharma institutions
  • Over 40 presentations focussed on the most innovative spatial and single cell technologies, and their applications within diagnostics, clinical research and drug discovery
  • Advance your understanding emerging single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics updates

Agenda at a Glance


  • Day One | Track 4: Emerging Single Cell Technologies
  • Day Two | Track 3: Bioinformatics For Single Cell Analysis
  • Day Two | Track 4: Applications Of Single Cell Technologies

Spatial Multi-Omics

Unlocking the Potential of Spatial Technologies 

Spatial Multi Omics are transforming drug development, allowing researchers to more precisely understand biological systems than ever before. At Spatial US, experts from across leading academic institutions and biopharma organizations showcase the most transformative spatial tools and their applications in target identification, biomarker discovery, translational research & Clinical Design. From data analytics to successful therapeutic case studies, it equips you with the information you need to successfully adopt spatial technologies into your workflows. 

  • Hear from and meet with the key innovators in spatial multi-omics. 2024 attendees included: Distinguished University Professor, George Mason University; Senior Scientist, AbbVie; Principal Scientist, Boehringer Ingelheim
  • New to 2025! Gain invaluable insights into novel multi-omics technologies for spatial genomics & transcriptomics. Presentations will include translating spatial imaging techniques & approaches into drug development multi-modality processing and spatial transcriptomic databases
  • New to 2025! Discuss spatial biology for oncology, immunology and neuroscience. Hear from expert speakers discussing the tumour environment, distribution of immune cells within the tumour and mapping cellular diversity in the brain  
  • New to 2025! Advance your understanding on novel multi-omics technologies for spatial proteomics & metabolomics: from developing novel technologies for protein analysis through to automated multi-omics workflows, spatial distribution of proteins within cell and distribution of metabolites at spatial resolution
  • Join a series of workshops, panel discussions & roundtables. Discussion sessions will include: ‘Overcoming the Challenges of Spatial Data Analysis’

Agenda at a Glance


  • Day One | Track 5: Novel Multi-Omic Technologies: Spatial Genomics & Transcriptomics
  • Day One | Track 6: Spatial Biology for Therapeutic Discovery & Development
  • Day Two | Track 5: Novel Multi-Omic Technologies: Spatial Proteomics & Metabolomics
  • Day Two | Track 6: Spatial Biology for Therapeutic Discovery & Development

 

What to Expect

1000

leading pharma, biotech, & academic delegates

60
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
62
hours of pre-arranged 1-2-1 meetings, facilitating business growth
ScipioBio

 

"The support from the Oxford Global team at NextGen Omics US 2024 was excellent - everyone went beyond to help us, it is rare to experience such support."


Chief Business Officer
Scipio Bio

b6fc1bbe-f2c7-48f4-ab7b-860f705182f9-2-5668375logo-logo-levitasbio-R-full-color-(1)

 

"Very professional and a high dedication to vendor needs and delivering on agreed upon packages. Christian is extremely attentive and customer driven, and this is also demonstrated by the Oxford Global team."

Senior Product Marketing Manager
Levitasbio

BD Logo-1

 

"NextGen Omics US was well organised, with highly relevant and enaged attendees."


Senior Sales Specalist, Single-Cell Multiomics
Business Development Manager – Northern Europe, Canopy Biosciences® – A Bruker Company

Exact Sciences Logo

"NextGen Omics US 2024 was a great networking opportunity, the meeting aspect of appointment setting was great. Everyone has been so helpful and responsive and ahead of our needs."


Regional Oncogenomic Liaison

Exact Sciences

Allumiqs

 

"NextGen Omics US 2024 was a great, we got good value out of it and are considering coming back to another event!"


Digital Marketing Manager

Allumiqs

Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 80 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Companies Represented Include

Meet Our Expert Speakers

The event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. Below were some of the featured speakers at NextGen Omics US 2024: 21 - 22 March 2024, Boston, MA, USA

Anna Lyubetskaya
Senior Principal Scientist,
Bristol Myers Squibb
Bin Li
Director, Computational Biology,
Takeda
Colles Price
Principal Scientist,
Takeda
Jasmine Plummer
Director,
St Jude Children's Research Hospital
Jindan Yu
Professor,
EMORY UNIVERSITY
Marina Bleck
Principal Scientist,
Boehringer Ingelheim Pharmaceuticals, Inc.
Ali Rahnavard
Assistant Professor,
The George Washington University
Amrut Sarangi
Computational Scientist,
Sanofi
Asaf Rotem
Senior Director,
AstraZeneca
Ashley Fletcher
Laboratory Manager / Bioinformatician,
Duke University
Changsheng Zhao
Associated professor,
Emory University
Cory White
Researcher,
Merck
Deidre Dalmas
Scientific Director,
GSK
Jason Kim
Professor and Director,
10x Genomics
Jeremy Huang
Senior Scientist - Single Cell & Systems Biology,
Sanofi
Josee Champagne
Associate Director, Clinical Development,
Northern Therapeutics
Josh Fienman
Senior Scientist, Genomics,
Pfizer
Jun Wang
Associate Professor,
Stony Brook University New York
Kan Xiong
Senior Scientist and Group Leader,
Broad Institute
Katy Borner
Victor H. Yngve Professor of Intelligent Systems Engineering,
Indiana University Bloomington
Kyoung Jae Won Won
Professor,
Cedars-Sinai Medical Center
Liguo Wang
Associate Professor in Biomedical Informatics,
Mayo Clinic
Lindsey Erion Barner
Senior Scientist,
Broad Institute of MIT and Harvard
Mandovi Chatterjee
Director, Single Cell Core,
Harvard Medical School
Monika Mehta
Senior Genomics Scientist,
Integrated Research Facility (NIAID)
Nikolai Slavov
Professor,
Northeastern University
Ron Weiss
Professor,
MIT
Serena Dollive
Senior Scientist II,
Oxford Biomedica
Shuqiang Li
Senior Scientist,
Broad Institute
Tom Defay
Deputy Head Diagnostics Strategy & Development,
Alexion Pharmaceuticals
Towia Libermann
Associate Professor of Medicine,
Beth Israel Deaconess Medical Center
Tujin Shi
Senior Scientist,
Pacific Northwest National Laboratory
Winston Hide
Associate Professor,
Beth Israel Deaconess Medical Center / Harvard Medical School
Xingyi Shi
Expert II Data Science,
Novartis
Yasser Riazalhosseini
Associate Professor,
McGill University
Yixing Han
Staff Scientist,
National Institutes of Health
Yong Zeng
Professor,
University of Florida

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Avicenna.AI Algorithms Pass EU Medical Devices Regulations

Compliance with MDR 2017/745 medical device regulation is a critical step toward European Union CE-mark authorisation.

Pixelgen Single Cell Spatial Proteomics Kit

Introducing the RNAscope™ Plus small RNA-RNA Fluorescent Assay

Spatially Intelligent SpaceIQ Platform

Transforming care for cancer patients

In situ functional cell phenotyping reveals microdomain networks in colorectal cancer recurrence

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Register Your Interest

Submit your details and a member of our team will be in touch